Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results
23 January 2026
1 min read

Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

New York, January 23, 2026, 15:22 EST — Regular session

  • Life360 shares surged roughly 22% following a preliminary Q4 update that highlighted record user and subscriber growth
  • Company raises its preliminary full-year 2025 revenue and adjusted EBITDA forecasts beyond earlier estimates
  • Investors are now eyeing March 2 for the full-year results and comprehensive guidance for 2026

Life360 shares surged roughly 22% on Friday following the family-safety app maker’s report of record fourth-quarter user growth and stronger-than-anticipated preliminary results. The stock climbed $12.09 to $66.90 in afternoon trading, hitting a high of $71.17 earlier in the day.

This move is significant since Life360 has started trading like a growth stock once more: investors are focusing heavily on app usage and subscriber growth as early indicators before the full-year results. A sharp change in the operational update can quickly shift expectations ahead of official guidance.

The timing is tricky for short-term positioning. While the update handed bulls new figures to lean on, it also raised the stakes for March, when management will need to clarify how much it plans to invest to sustain growth.

Life360 reported that global monthly active users (MAU)—the number of people using its app monthly—jumped to 95.8 million in Q4. The company’s paying circles, or subscription groups, hit 2.8 million. Life360 noted strong momentum both in the U.S. and internationally, and maintained its forecast of about 20% MAU growth in 2026. 1

Life360’s preliminary unaudited numbers point to full-year 2025 revenue between $486 million and $489 million, with adjusted EBITDA landing in the $87 million to $92 million range. Adjusted EBITDA excludes interest, taxes, and certain non-cash expenses, offering a clearer view of operating trends. 2

Chief Executive Officer Lauren Antonoff declared, “Q4 2025 represents our strongest operational performance in company history,” highlighting record user additions and subscriber growth. 3

Life360 announced it will release its full-year 2025 results along with detailed guidance for 2026 on March 2 in the U.S. Australian investors should note the update will come on March 3 (AEDT). 4

The company released its operational update via a Form 8-K filing on Thursday, a document that companies use to notify U.S. regulators of significant developments. 5

These figures remain preliminary, and the jump hardly suggests a milder outlook for March. Investors will be watching closely to see how much user growth converts into paid subscriptions, and if planned spending on growth eats into margin improvements.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February
Previous Story

Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February

Qualcomm stock slips today as QCOM proxy vote and Feb. 4 earnings draw focus
Next Story

Qualcomm stock slips today as QCOM proxy vote and Feb. 4 earnings draw focus

Go toTop